MARKET

AMRX

AMRX

Amneal Pharmaceuticals Inc
NASDAQ
5.90
-0.15
-2.48%
After Hours: 6.00 +0.1 +1.69% 19:00 04/25 EDT
OPEN
5.97
PREV CLOSE
6.05
HIGH
5.97
LOW
5.59
VOLUME
3.43M
TURNOVER
0
52 WEEK HIGH
6.46
52 WEEK LOW
1.580
MARKET CAP
1.82B
P/E (TTM)
-12.3716
1D
5D
1M
3M
1Y
5Y
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
NASDAQ · 22h ago
Analysts Conflicted on These Healthcare Names: Amneal Pharmaceuticals (AMRX) and Community Health (CYH)
TipRanks · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Globe Life, EQT, Ribbon Communications
Wall Street's main indexes pared early gains to trade lower on Wednesday. Dow Jones Industrial Average .DJI was down 0.11% at 38,460.49. Top three S&P 500 percentage gainers: Tesla Inc, Hasbro and Visa. Positive earnings across several sectors and rising Treasury yields pressured equities.
Reuters · 1d ago
Amneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spray
Amneal Pharmaceuticals shares were up 9% after the FDA approved an abbreviated new drug application. The company's stock hit a 52-week high of $6.46 on March 19. Naloxone nasal spray is a medication used to help treat drug overdose from opioids.
Dow Jones · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-MSCI, Globe Life, EQT Corp
The Nasdaq outpaced Wall Street peers on Wednesday. Tesla leads gains among megacap stocks after its quarterly results. The Dow Jones Industrial Average was down 0.35% at 38,368.64. The top three S&P 500 percentage gainers were Hasbro and Texas Instruments.
Reuters · 1d ago
FDA approves Amneal's generic version of OTC Narcan
FDA approves Amneal Pharmaceuticals’ OTC Naloxone HCl nasal spray, a generic version of the opioid overdose medication OTC Narcan. Narcan is marketed by drugmaker Emergent Biosolutions. Bausch Health filed a patent infringement suit against the company earlier this month.
Seeking Alpha · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Biogen, Humana, gold miners
The S&P 500 and the Nasdaq were set to open higher on Wednesday. Tesla leads gains among megacap stocks after its quarterly results. Biogen, Humana, gold miners also rise after upbeat earnings reports. Dow e-minis were down 0.15% in early trading.
Reuters · 1d ago
Amneal's OTC Naloxone Nasal Spray Receives FDA Approval For Opioid Overdose Emergency Treatment
NASDAQ · 1d ago
More
About AMRX
Amneal Pharmaceuticals, Inc., is a fully integrated global essential medicine company. The Company is engaged in the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. The Company’s Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermal across a broad range of therapeutic categories. The Company's Specialty segment’s portfolio includes central nervous system disorders (Parkinson’s disease, spasticity, migraine), endocrinology (hypothyroidism), and other therapeutic areas. The Company’s AvKARE segment provides pharmaceuticals, medical and surgical products, and services to government, retail, and institutional markets.

Webull offers Amneal Pharmaceuticals Inc stock information, including NASDAQ: AMRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRX stock methods without spending real money on the virtual paper trading platform.